Contact us





    *Required

    June 2, 2026

    Kemp Proteins Selected by Avivo Biomedical to Support Process Optimization for Universal Blood Technology Program

    Kemp Proteins will support upstream and downstream process optimization and manufacturing efforts for Avivo’s proprietary enzyme platform, which is designed to convert type A, B, and AB blood into universal donor type O blood.